Rising Demand For Blood Transfusions Fuels Growth In The Sickle Cell Disease Treatment Market Driver: A Major Catalyst in the Evolution of the Sickle Cell Disease Treatment Market in 2025

How Is the Sickle Cell Disease Treatment Market Projected to Grow, and What Is Its Market Size?
The sickle cell disease treatment market has seen rapid growth in recent years. It will rise from $2.95 billion in 2024 to $3.54 billion in 2025, at a CAGR of 19.7%. The growth is attributed to advancements in disease understanding, blood transfusions, pain management, and the use of hydroxyurea therapy.

The sickle cell disease treatment market is expected to grow rapidly, reaching $6.8 billion by 2029, with a CAGR of 17.7%. The growth is driven by gene editing and therapy advancements, new drug development, telemedicine, and global health initiatives. Key trends include curative therapies, pain management alternatives, global collaborations, and patient advocacy.

What Are the Key Drivers Behind the Growth of the Sickle Cell Disease Treatment Market?
The rising demand for blood transfusions is expected to support the expansion of the sickle cell disease treatment market in the coming years. A blood transfusion is a medical procedure in which blood or blood components are transferred from a donor to a recipient. For individuals with sickle cell disease (SCD), blood transfusions are essential as they improve oxygen-carrying capacity and reduce complications related to vaso-occlusion. For example, in January 2022, according to Mid-Atlantic Long-Term Care, a US-based specialized medical service provider, approximately 29,000 units of red blood cells, 5,000 units of platelets, and 6,500 units of plasma were required daily in the US. Consequently, the growing need for blood transfusions is accelerating the growth of the sickle cell disease treatment market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13048&type=smp

Who Are the Major Industry Players Fueling Sickle Cell Disease Treatment Market Expansion?
Major companies operating in the sickle cell disease treatment market are Sun Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Silver Lake Research Corporation0.45, Global Blood Therapeutics Inc., Acceleron Pharma Inc., Sangamo Therapeutics Inc., Medunik USA Inc., Zydus Cadila Healthcare Ltd., Graphite Bio Inc., Addmedica, Emmaus Medical Inc., Bluebird bio Inc., CRISPR Therapeutics AG, GlycoMimetics Inc., Arena Pharmaceuticals Inc., Mast Therapeutics Inc.

Which Key Developments Are Influencing the Sickle Cell Disease Treatment Market?
Leading companies in the sickle cell disease treatment market are developing oral suspension drugs to enhance patient compliance, improve efficacy, and offer convenient treatment options for pediatric and elderly patients. Oral suspension drugs consist of liquid formulations with solid particles, making them easier to ingest compared to pills. In March 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical company, launched a room temperature-stable oral suspension of Hydroxyurea. This cost-effective treatment for sickle cell disease (SCD) is priced at less than 1% of imported alternatives. It provides accurate dosing with oral syringes and is accessible to patients of all ages without requiring refrigeration.

How Is the Segmentation of the Sickle Cell Disease Treatment Market Defined?
The sickle cell disease treatment market covered in this report is segmented -

1) By Treatment Modality: Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant
2) By Disease Type: Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), Other Disease Types
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Blood Transfusion: Regular Blood Transfusion, Exchange Transfusion
2) By Pharmacotherapy: Hydroxyurea, L-Glutamine, Voxelotor, Crizanlizumab
3) By Bone Marrow Transplant: Allogeneic Transplant, Autologous Transplant

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report

What Is the Leading Region in the Sickle Cell Disease Treatment Market?
North America was the largest region in the sickle cell disease treatment market in 2024. The regions covered in sickle cell disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Sickle Cell Disease Treatment Global Market Report?

- Market Size Analysis: Analyze the Sickle Cell Disease Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Sickle Cell Disease Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Sickle Cell Disease Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Sickle Cell Disease Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13048

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.